Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.5990
0.00 (0.00%)
At close: Apr 15, 2026
Orgenesis Revenue
In the year 2024, Orgenesis had annual revenue of $1.04M with 95.28% growth. Orgenesis had revenue of $347.00K in the quarter ending September 30, 2024, with 215.45% growth.
Revenue
1.04M
Revenue Growth
+95.28%
P/S Ratio
5.67
Revenue / Employee
13.44K
Employees
77
Market Cap
5.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.04M | 505.00K | 95.28% |
| Dec 31, 2023 | 530.00K | -35.50M | -98.53% |
| Dec 31, 2022 | 36.03M | 523.00K | 1.47% |
| Dec 31, 2021 | 35.50M | 27.85M | 363.96% |
| Dec 31, 2020 | 7.65M | 3.75M | 96.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| LakeShore Biopharma | 84.75M |
| Carisma Therapeutics | 52.63M |
| Clearside Biomedical | 3.33M |
| Avenue Therapeutics | 1.40M |
| Enzolytics | 46.59K |
Orgenesis News
- 20 days ago - Okogen Acquires Ranpirnase Assets and Intellectual Property Portfolio - Newsfile Corp
- 1 year ago - Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies - Accesswire
- 1 year ago - Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings - Accesswire
- 1 year ago - Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia - GlobeNewsWire
- 1 year ago - Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally - GlobeNewsWire
- 2 years ago - Orgenesis Provides Business Update for the First Quarter of 2024 - GlobeNewsWire
- 2 years ago - Orgenesis Provides Year End Business Update - GlobeNewsWire
- 2 years ago - Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility - GlobeNewsWire